Annie Fromentin

1.6k total citations
17 papers, 1.4k citations indexed

About

Annie Fromentin is a scholar working on Molecular Biology, Immunology and Cell Biology. According to data from OpenAlex, Annie Fromentin has authored 17 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Immunology and 4 papers in Cell Biology. Recurrent topics in Annie Fromentin's work include Cell death mechanisms and regulation (6 papers), Heat shock proteins research (6 papers) and Phagocytosis and Immune Regulation (4 papers). Annie Fromentin is often cited by papers focused on Cell death mechanisms and regulation (6 papers), Heat shock proteins research (6 papers) and Phagocytosis and Immune Regulation (4 papers). Annie Fromentin collaborates with scholars based in France, Tunisia and United States. Annie Fromentin's co-authors include Carmen Garrido, Éric Solary, Arlette Hammann, Jean‐Marie Bruey, André Patrick Arrigo, Patrick Mehlen, Bernard Bonnotte, Bruno Chauffert, André‐Patrick Arrigo and Monique Moutet and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Oncogene.

In The Last Decade

Annie Fromentin

17 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annie Fromentin France 14 1.1k 315 305 231 103 17 1.4k
Patrick Fadden United States 13 1.4k 1.3× 264 0.8× 182 0.6× 119 0.5× 144 1.4× 21 1.7k
Kim Milarski United States 17 1.7k 1.6× 260 0.8× 709 2.3× 257 1.1× 141 1.4× 18 2.2k
Anna Rodina United States 20 1.6k 1.5× 326 1.0× 260 0.9× 194 0.8× 191 1.9× 32 2.1k
Gérard Crémel France 21 950 0.9× 184 0.6× 164 0.5× 353 1.5× 153 1.5× 59 1.6k
Augustine Y. Lin United States 12 810 0.8× 368 1.2× 326 1.1× 127 0.5× 115 1.1× 17 1.3k
Yuka Nakajima Japan 20 754 0.7× 84 0.3× 95 0.3× 221 1.0× 53 0.5× 44 1.4k
Ren Liu United States 18 874 0.8× 280 0.9× 127 0.4× 214 0.9× 38 0.4× 46 1.3k
Takanobu Kikuchi Japan 19 687 0.6× 229 0.7× 95 0.3× 118 0.5× 94 0.9× 38 1.2k
Tomoko Yaguchi Japan 20 777 0.7× 158 0.5× 50 0.2× 222 1.0× 124 1.2× 25 1.0k
Elena Beltrami Italy 11 959 0.9× 113 0.4× 235 0.8× 319 1.4× 61 0.6× 15 1.2k

Countries citing papers authored by Annie Fromentin

Since Specialization
Citations

This map shows the geographic impact of Annie Fromentin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annie Fromentin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annie Fromentin more than expected).

Fields of papers citing papers by Annie Fromentin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annie Fromentin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annie Fromentin. The network helps show where Annie Fromentin may publish in the future.

Co-authorship network of co-authors of Annie Fromentin

This figure shows the co-authorship network connecting the top 25 collaborators of Annie Fromentin. A scholar is included among the top collaborators of Annie Fromentin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annie Fromentin. Annie Fromentin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Schmitt, E., Arnaud Parcellier, François Ghiringhelli, et al.. (2004). Increased Immunogenicity of Colon Cancer Cells by Selective Depletion of Cytochromec. Cancer Research. 64(8). 2705–2711. 16 indexed citations
2.
Larmonier, Nicolas, François Ghiringhelli, Claire B. Larmonier, et al.. (2003). Freshly isolated bone marrow cells induce death of various carcinoma cell lines. International Journal of Cancer. 107(5). 747–756. 19 indexed citations
3.
Larmonier, Nicolas, Cédric Rébé, Arnaud Parcellier, et al.. (2002). An atypical caspase-independent death pathway for an immunogenic cancer cell line. Oncogene. 21(39). 6091–6100. 13 indexed citations
4.
Bonnotte, Bernard, Nicolas Larmonier, Nathalie Favre, et al.. (2001). Identification of Tumor-Infiltrating Macrophages as the Killers of Tumor Cells After Immunization in a Rat Model System. The Journal of Immunology. 167(9). 5077–5083. 61 indexed citations
5.
Gurbuxani, Sandeep, Jean-Marie Bruey, Annie Fromentin, et al.. (2001). Selective depletion of inducible HSP70 enhances immunogenicity of rat colon cancer cells. Oncogene. 20(51). 7478–7485. 67 indexed citations
6.
Bonnotte, Bernard, Nathalie Favre, Monique Moutet, et al.. (2000). Role of Tumor Cell Apoptosis in Tumor Antigen Migration to the Draining Lymph Nodes. The Journal of Immunology. 164(4). 1995–2000. 43 indexed citations
7.
Fromentin, Annie, et al.. (2000). Cutting Edge: The Tumor Counterattack Hypothesis Revisited: Colon Cancer Cells Do Not Induce T Cell Apoptosis Via the Fas (CD95, APO-1) Pathway. The Journal of Immunology. 164(10). 5023–5027. 65 indexed citations
8.
Martin, Monique, Eugene Maraskovsky, Annie Fromentin, et al.. (2000). Flt3 ligand lessens the growth of tumors obtained after colon cancer cell injection in rats but does not restore tumor-suppressed dendritic cell function. International Journal of Cancer. 86(6). 827–834. 20 indexed citations
9.
Bruey, Jean‐Marie, Catherine Paul, Annie Fromentin, et al.. (2000). Differential regulation of HSP27 oligomerization in tumor cells grown in vitro and in vivo. Oncogene. 19(42). 4855–4863. 108 indexed citations
10.
Favre, Nathalie, et al.. (1999). FAS(CD95) ligand expression by tumor cell variants can be unrelated to their capacity to induce tolerance or immune rejection. International Journal of Cancer. 82(3). 359–367. 5 indexed citations
11.
Garrido, Carmen, Jean‐Marie Bruey, Annie Fromentin, et al.. (1999). HSP27 inhibits cytochrome c‐dependent activation of procaspase‐9. The FASEB Journal. 13(14). 2061–2070. 428 indexed citations
12.
Bonnotte, Bernard, Nathalie Favre, Monique Moutet, et al.. (1998). Bcl-2-Mediated Inhibition of Apoptosis Prevents Immunogenicity and Restores Tumorigenicity of Spontaneously Regressive Tumors. The Journal of Immunology. 161(3). 1433–1438. 45 indexed citations
13.
Garrido, Carmen, Annie Fromentin, Bernard Bonnotte, et al.. (1998). Heat shock protein 27 enhances the tumorigenicity of immunogenic rat colon carcinoma cell clones.. PubMed. 58(23). 5495–9. 148 indexed citations
14.
Garrido, Carmen, Annie Fromentin, Arlette Hammann, et al.. (1997). HSP27 as a mediator of confluence-dependent resistance to cell death induced by anticancer drugs.. PubMed. 57(13). 2661–7. 208 indexed citations
15.
Garrido, Carmen, Patrick Mehlen, Annie Fromentin, et al.. (1996). Inconstant Association between 27‐kDa Heat‐Shock Protein (Hsp27) Content and Doxorubicin Resistance in Human Colon Cancer Cells. European Journal of Biochemistry. 237(3). 653–659. 73 indexed citations
16.
Coppey, J., et al.. (1986). Altered distribution of copper (64Cu) in tumor-bearing mice and rats.. PubMed. 6(2). 159–64. 72 indexed citations
17.
Guillé, E., et al.. (1985). 64Cu and krebs ascitic tumour in mice: Dose effect relationships. European Journal of Cancer and Clinical Oncology. 21(11). 1386–1386. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026